# Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose

> **NCT02811185** · PHASE4 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 1012 (actual)

## Conditions studied

- Positron-Emission Tomography and Cone-Beam Computed Tomography

## Interventions

- **DRUG:** [F-18]-Fludeoxyglucose

## Key facts

- **NCT ID:** NCT02811185
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-01
- **Final completion:** 2017-01-30
- **Target enrollment:** 1012 (ACTUAL)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02811185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02811185, "Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02811185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*